Abstract
Neonatal hypoxic-ischemic encephalopathy(HIE)is a common disease in neonatal nervous system injury, which often treated by the traditional measures such as three support′s and three symptomatic treatments.Moreover, there is no specific treatment nowadays.The human umbilical cord mesenchymal stem cells(HUC-MSC)are mixture of multifunctional stem cells from neonatal umbilical cord tissues, which has strong abilities of self-renewal and multilineage differentiation potential.HUC-MSC are easy to harvest and have more sources, low immunogenicity and without ethical problems.It can differentiate into neural cells under certain conditions, secrete neurotrophic factors, repair the damaged brain and promote the recovery of cerebral function.Transplantation of HUC-MSC provides a new way for the treatment of HIE. Key words: Human umbilical cord mesenchymal stem cell; Newborn; Hypoxic-ischemic encephalopathy; Transplantation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
